1. Home
  2. SVRA vs CLFD Comparison

SVRA vs CLFD Comparison

Compare SVRA & CLFD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVRA
  • CLFD
  • Stock Information
  • Founded
  • SVRA 2007
  • CLFD 1979
  • Country
  • SVRA United States
  • CLFD United States
  • Employees
  • SVRA N/A
  • CLFD N/A
  • Industry
  • SVRA Biotechnology: Pharmaceutical Preparations
  • CLFD Telecommunications Equipment
  • Sector
  • SVRA Health Care
  • CLFD Utilities
  • Exchange
  • SVRA Nasdaq
  • CLFD Nasdaq
  • Market Cap
  • SVRA 528.3M
  • CLFD 576.5M
  • IPO Year
  • SVRA N/A
  • CLFD N/A
  • Fundamental
  • Price
  • SVRA $2.21
  • CLFD $44.43
  • Analyst Decision
  • SVRA Buy
  • CLFD Strong Buy
  • Analyst Count
  • SVRA 5
  • CLFD 3
  • Target Price
  • SVRA $5.60
  • CLFD $46.67
  • AVG Volume (30 Days)
  • SVRA 1.2M
  • CLFD 107.1K
  • Earning Date
  • SVRA 08-11-2025
  • CLFD 07-31-2025
  • Dividend Yield
  • SVRA N/A
  • CLFD N/A
  • EPS Growth
  • SVRA N/A
  • CLFD N/A
  • EPS
  • SVRA N/A
  • CLFD N/A
  • Revenue
  • SVRA N/A
  • CLFD $178,209,000.00
  • Revenue This Year
  • SVRA N/A
  • CLFD $10.77
  • Revenue Next Year
  • SVRA N/A
  • CLFD $14.46
  • P/E Ratio
  • SVRA N/A
  • CLFD N/A
  • Revenue Growth
  • SVRA N/A
  • CLFD N/A
  • 52 Week Low
  • SVRA $1.89
  • CLFD $23.78
  • 52 Week High
  • SVRA $5.11
  • CLFD $44.83
  • Technical
  • Relative Strength Index (RSI)
  • SVRA 41.30
  • CLFD 75.97
  • Support Level
  • SVRA $1.98
  • CLFD $42.01
  • Resistance Level
  • SVRA $2.29
  • CLFD $43.90
  • Average True Range (ATR)
  • SVRA 0.14
  • CLFD 1.18
  • MACD
  • SVRA 0.02
  • CLFD 0.20
  • Stochastic Oscillator
  • SVRA 42.19
  • CLFD 96.37

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

About CLFD Clearfield Inc.

Clearfield Inc mainly designs, manufactures, and distributes fiber protection, fiber management and fiber delivery solutions for communications networks. It provides a various products including copper assemblies, cassettes, box enclosures, fiber connectors, frames, microduct, terminals, vaults, pedestal inserts, FieldSmart, WaveSmart, and CraftSmart. The company has international presence with the majority of the revenue derived from the United States. The company has two reportable segments namely Clearfield segment and Nestor cables segment. The majority of revenue is derived from Clearfield segment.

Share on Social Networks: